An interventional study of Strength and Sensorimotor in Patellofemoral Pain Syndrome, sponsored by University of Nove de Julho. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2016-10-25.
Sponsored by University of Nove de Julho · Not applicable, Interventional, and Treatment
Assess pain, function, trunk and lower limbs kinematic during functional tasks after hip muscle strengthening versus hip muscle strengthening and sensory motor training in lower limbs.
295 studies on the registry are indexed under Patellofemoral Pain Syndrome; 75 are open to participants now.
This study's enrollment of 34 is below the median of 45 across 242 interventional studies indexed under Patellofemoral Pain Syndrome.
Browse Patellofemoral Pain Syndrome studies →University of Nove de Julho is the lead sponsor of 239 studies on the registry; 51 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 1 (13%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Sensorimotor, this arm will receive sensorimotor and hip muscle strengthening.
Other: Sensorimotor
Strength, this arm will receive only hip muscle strengthening.
Other: Strength
Also known as: Hip abductors and lateral rotators and knee extensors strengthening
Also known as: Sensorimotor, balancing exercises, motor coordination, proprioceptive stimuli.
Function and pain intensity
Time frame: 4 weeks
Muscle strength of the hip and knee muscles
Time frame: 4 weeks
Three-dimensional kinematics of the trunk and lower limbs during the step down task
Time frame: 4 weeks
Function and pain intensity
Time frame: 3 and 6 months after randomization
This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Nove de Julho